Biosensor developer Biolinq said today it raised $4.8 million as an extension of its Series A financing round.
The San Diego-based company said that the investment in its expanded, oversubscribed Series A round was led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. With the additional funding, Biolinq said it has raised a total of $15 million in the Series A round.
Read the whole story on our sister site, Drug Delivery Business News
The post Biolinq adds $5m to Series A appeared first on MassDevice.
from MassDevice https://ift.tt/2HWbqm8
Cap comentari:
Publica un comentari a l'entrada